ACTRN12607000420448已完成1 期
Evaluation of an orally-bioactive form of Superoxide Dismutase, GliSODin, in reducing levels of fatigue in otherwise healthy women aged between 50-65 years over a 12-week period.
Applied Science & Nutrition0 个研究点目标入组 40 人开始时间: 2007年8月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 65 Years(—)
- 性别
- Female
入选标准
- •Unexplained fatigue of greater than 3 months' duration
排除标准
- •Clinical Depression, Diagnosed Thyroid Disorder, Iron-deficiency anaemia, Coeliac Disease, Any serious disease, History of Alcohol or Drug Abuse, Primary Sleep Disorder
研究者
相似试验
尚未招募
1 期
Safety of Orally Administered Neutral pH Super Oxidation Electrolyzed SolutioHealthyHealthy VolunteersRPCEC00000427Esteripharma Laboratory30
招募中
不适用
Oral administration of sucroferric oxyhydroxide during hemodialysis sessions against resistant hyperphosphatemiaResistant hyperphosphatemia in maintenance hemodialysis patientsJPRN-UMIN000031337Dialysis Center, JA Toride Medical Center20
招募中
3 期
Investigating the effect of organosulfur compounds on children's lung infectionsPneumonia.Bronchopneumonia, unspecified organismJ18.0IRCT20221129056657N2Hossein Niktale - the inventor of medicine70
已完成
不适用
Study of the efficacy of sucroferric oxyhydroxide (chewable tablet) on the control of CKD-MBD and improvement of renal anemia in hemodialysis patients with hyperphosphatemia.Hyperphosphatemia in chronic kidney disease patients on hemodialysisJPRN-UMIN000023657Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group50
招募中
4 期
Investigation of the effect of oral ursodeoxycholic acid drug in neonatal jaundiceIRCT20130313012803N3Rasht University of Medical Sciences106
